News

The company also announced that it has received corresponding patents from the South African and the New Zealand Patent Offices. In addition to these newly issued patents, the

The letter follows a routine FDA inspection of GlaxoSmithKline’s (GSK’s) reporting processes conducted last year. The observations from the inspection primarily relate to omissions from periodic reports to

The Halo Research Platform is for basic research scientists in academia and other research institutions. The Halo Stem and Progenitor Cell, Quality Control (SPC-QC) and Halo-96 PQR (Potency,

The trial in healthy volunteers is being conducted in the UK to evaluate aerosol delivery by assessing lung distribution, pharmacokinetics and safety of inhaled treprostinil delivered by the

The Raven technology platform has generated well-characterized, high-affinity monoclonal antibodies to proteins on the cell surface that can be used to quickly identify and validate targets. The platform

The study will evaluate the efficacy and tolerability of APD125 in patients with primary insomnia characterized by difficulty maintaining sleep. The trial, which is expected to enroll a

Under the terms of the agreement, Achillion will pay to FOB a $500,000 upfront license payment, and FOB could also earn additional license and milestone payments of up

The activities associated with patient screening have commenced and the company expects to enroll the first patient during the second quarter of 2008. The goal of this Phase

Under the terms of the agreement, Iverson Genetics will use ParagonDx’s products to test patients to determine if they possess genetic traits shown to increase or decrease sensitivity